#doximity

[ follow ]
#pharmaceutical-digital-marketing #stock-rating #revenue-guidance #earnings-estimates #price-target
Business
fromInvesting.com Australia
4 days ago

Mizuho cuts Doximity stock price target on weaker growth outlook By Investing.com

Mizuho cut Doximity’s price target to $26 and kept a Neutral rating due to weaker fiscal 2027 growth guidance and reduced industry marketing spend.
fromInvesting.com South Africa
4 days ago

Mizuho cuts Doximity stock price target on weaker growth outlook By Investing.com

Mizuho lowered its price target on Inc () to $26 from $34 on Thursday while maintaining a Neutral rating on the shares. The stock currently trades at $23.39, down 53% over the past six months and 47% year-to-date. The firm cited the company's more muted growth outlook for fiscal year 2027 as the reason for the price target reduction.
Business
Business
from24/7 Wall St.
5 months ago

Analysts See More Upside for this Rallying Cruise Stock

Jefferies upgraded Viking to buy with an $80 target, citing strong revenue, EBITDA, EPS growth and >100% free cash flow conversion.
[ Load more ]